findmyKOL

Nishant Tageja, MD

Basic profile

UPMC Hillman Cancer Center

ORCIDNone on fileNPI
RegionGreensburg, PA · NortheastSpecialtyHematology / OncologyFocusOncology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Nishant Tageja is an Oncology physician affiliated with UPMC Hillman Cancer Center. OpenAlex indexes 100 publications with 1,463 citations (h-index 21).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
100publications

Distinct works indexed by OpenAlex.

1,463citations

Total citations across indexed works.

21h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
6companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

200 Village Dr
Greensburg, PA 156013783

Telephone

724-838-1900

Registry record last updated 21 Jul 2022.

View the NPPES registry record

Industry payments

6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    43.8%
    Kinase inhibitor12.2%
    Brukinsa31%Verzenio19%Imbruvica18%Inlyta14%Imatinib Mesylate9%Lorbrena9%
    Part D<11 patients
    Aromatase Inhibitor10.4%
    Anastrozole100%
    Part D36 patients

    + 6 more classes in this area

  • Blood & clotting

    21.7%
    Factor Xa inhibitor19.4%
    Eliquis82%Xarelto18%
    Part D49 patients
    Low Molecular Weight Heparin2.3%
    Enoxaparin Sodium100%
    Part D19 patients
  • Metabolism & gastrointestinal

    12%
    Serotonin-3 Receptor Antagonist8.6%
    Ondansetron Odt51%Ondansetron Hcl50%
    Part D28 patients
    Corticosteroid3.4%
    Prednisone100%
    Part D22 patients
Where care is delivered (Part B)31.6% facility · 68.4% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”